Lv11
20 积分 2025-05-20 加入
隐姓埋名的打工仔！
Mechanisms of drug combinations: interaction and network perspectives
1小时前
待确认
Flumatinib versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study
15天前
已完结
Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial
28天前
已完结
CAR T-cell Therapy for Central Nervous System Lymphoma
29天前
已完结
Red blood cells undergo lytic programmed cell death involving NLRP3
1个月前
已完结
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma
1个月前
已完结
[Guidelines for the diagnosis and management of multiple myeloma in China (2024 revision)]
1个月前
已完结
Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma
1个月前
已完结
Lenalidomide plus dexamethasone for patients with relapsed or refractory multiple myeloma: Final results of a non-interventional study and comparison with the pivotal phase 3 clinical trials
1个月前
已完结
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
